Table 1 Study characteristics of prognostic model studies using flexible parametric survival models
Author (year) | Country | Topic area of research | Data source | Study setting | Sample size | Maximum follow-up time | Timescale | Event/outcome | Number of events |
|---|---|---|---|---|---|---|---|---|---|
Andersson et al. (2014) [34] | Sweden | Cancer | Administrative data | Country | 5850 | 15Â years | Calendar time | Mortality | 1951 |
Baade et al. (2015) [33] | Australia | Cancer | Administrative data | Country | 870,878 | 21Â years | Calendar time | Mortality | 261,720 |
Baade et al. (2015) [41] | Australia | Cancer | Administrative data | Secondary care | 28,654 | 16Â years | Calendar time | Mortality | 5469 |
Castillo et al. (2013) [38] | United States of America | Cancer | Administrative data | Primary care | 2284 | 12Â years | Calendar time | Mortality | 1210 |
Csordas et al. (2016) [37] | Switzerland | Cardiovascular | Clinical data | Hospital | 185 | 222Â days | Calendar time | Mortality | 17 |
Eyre et al. (2012) [40] | United Kingdom | Infectious disease | Administrative data | Hospital | 1678 | 4.6Â years | Calendar time | Clostridium difficile infection recurrence | 363 |
Fox et al. (2014) [32] | United Kingdom | Cancer | Clinical data | Hospital | 2918 | Not stated | Calendar time | Mortality | Not stated |
Li et al. (2016) [39] | United Kingdom | Organ transplant | Administrative data | Secondary care | 12,307 | 10Â years | Calendar time | Mortality | 1503 |
Miladinovic et al. (2012) [30] | United States of America | Aging | Medical records | Hospice | 590 | 371Â days | Calendar time | Mortality | 590 |
Myklebust et al.(2016) [31] | Norway | Cancer | Administrative data | Country | 805,365 | 15Â years | Calendar time | Mortality | Not stated |
Ramezani Tehrani et al. (2016) [35] | Iran | Reproductive/perinatal | Population survey | Community | 1015 | 12.3Â years | Age | Menopause | 277 |
Sanchis et al. (2014) [36] | Spain | Cardiovascular | Clinical data | Hospital | 342 | 34Â months | Calendar time | Mortality | 74 |